Status:
UNKNOWN
VR-based Exposure Training for Adolescents With Fear of Public Speaking
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
Stockholm University
Conditions:
Mental Health Issue
Adolescent Development
Eligibility:
All Genders
13-16 years
Phase:
NA
Brief Summary
Public speaking anxiety (PSA) is a common anxiety with onset in adolescence and early adulthood. With the advent of consumer Virtual Reality (VR) technology, VR-delivered exposure therapy has previous...
Detailed Description
The study is a two-phased intervention study . Participants with PSA will be randomized into three self-guided intervention groups and one delayed waiting list group as follows: Group 1: receiving V...
Eligibility Criteria
Inclusion
- Inclusion:
- Aged 13-16, Symptoms of PSA, as defined by Public Speaking Anxiety Scale (PSAS) which leads to distress and / or negative consequences at school. Based on data from the feasibility study (Kahlon et.al 2019) the cut-off will be PSAS \< 55.
- \-
Exclusion
- Current ongoing treatment for mental health problems (psychoactive medication/psychotherapy) impaired eyesight and lack of stereoscopic vision which cause difficulties in the VR experience and balance problems
- \-
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04396392
Start Date
March 1 2020
End Date
March 3 2022
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bergen Municipality Division School
Bergen, Vestland, Norway, 5003